Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12609000883213
Ethics application status
Approved
Date submitted
6/10/2009
Date registered
9/10/2009
Date last updated
12/01/2018
Type of registration
Prospectively registered

Titles & IDs
Public title
Prospective observational longitudinal registry of patients with stable coronary artery disease
Scientific title
Prospective observational longitudinal registry of patients with stable coronary artery disease
Secondary ID [1] 283789 0
Nil Known
Universal Trial Number (UTN)
Trial acronym
CLARIFY
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Coronary Artery Disease 251964 0
Condition category
Condition code
Cardiovascular 252150 252150 0 0
Coronary heart disease

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Observation of standard management of coronary artery disease patients over a 5 year period. Observations will be recorded at baseline and then every 12 months for 5 years. Data will be recorded detailing; patient demographics, cardiovascular risk factors, medical history, physical status (height, weight, electrocardiogram, blood test results for lipids and glucose) and current medications.
Intervention code [1] 241378 0
Not applicable
Comparator / control treatment
No treatment
Control group
Uncontrolled

Outcomes
Primary outcome [1] 253022 0
To characterise contemporary coronary artery disease (CAD) patients in terms of; demographic characteristics, clinical profiles and management and outcomes to identify gaps between treatment and evidence
Timepoint [1] 253022 0
5 years after recruitment
Secondary outcome [1] 257835 0
To determine the long term prognostic determinants in this population, including resting heart rate (measured using an electrcardiogram), with a view to developing a risk prediction model. A statistic regression model will be used to determine the factors with prognostic importance.
Timepoint [1] 257835 0
5 years after recruitment

Eligibility
Key inclusion criteria
Outpatients with stable coronary artery disease proven by history of at least one of the following criteria:
- documented myocardial infarction (>3months ago)
- coronary angiography showing at least one coronary stenosis of more than 50%
- chest pain with myocardial ischaemia proven by stress electrocardiogram, stress echocardiography or myocardial imaging
- coronary artery bypass graft or percutaneous coronary intervention (>3 months ago)
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Patients hospitalised for cardiovascular disease within last 3 months (including revascularisation)
- Patients with planned revascularisation
- Conditions hampering participation in the 5 year follow up, such as limited cooperation, limited legal capacity, serious non-cardiovascular disease or conditions interfering with life expectancy (cancer, drug abuse etc) or severe cardiovascular disease (advanced heart failure, severe valve disease, history of valve repair/replacement etc)

Study design
Purpose
Natural history
Duration
Longitudinal
Selection
Defined population
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/12/2009
Actual
18/02/2010
Date of last participant enrolment
Anticipated
Actual
28/06/2010
Date of last data collection
Anticipated
Actual
30/09/2015
Sample size
Target
30000
Accrual to date
Final
32703
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,WA,VIC
Recruitment outside Australia
Country [1] 2222 0
France
State/province [1] 2222 0
Country [2] 2223 0
Austria
State/province [2] 2223 0
Country [3] 2224 0
Belgium
State/province [3] 2224 0
Country [4] 2225 0
Denmark
State/province [4] 2225 0
Country [5] 2226 0
Finland
State/province [5] 2226 0
Country [6] 2227 0
Germany
State/province [6] 2227 0
Country [7] 2228 0
Greece
State/province [7] 2228 0
Country [8] 2229 0
Ireland
State/province [8] 2229 0
Country [9] 2230 0
Italy
State/province [9] 2230 0
Country [10] 2231 0
Netherlands
State/province [10] 2231 0
Country [11] 2232 0
Portugal
State/province [11] 2232 0
Country [12] 2233 0
Spain
State/province [12] 2233 0
Country [13] 2234 0
Switzerland
State/province [13] 2234 0
Country [14] 2235 0
United Kingdom
State/province [14] 2235 0
Country [15] 2236 0
Bulgaria
State/province [15] 2236 0
Country [16] 2237 0
Czech Republic
State/province [16] 2237 0
Country [17] 2238 0
Hungary
State/province [17] 2238 0
Country [18] 2239 0
Latvia
State/province [18] 2239 0
Country [19] 2240 0
Poland
State/province [19] 2240 0
Country [20] 2241 0
Romania
State/province [20] 2241 0
Country [21] 2242 0
Russian Federation
State/province [21] 2242 0
Country [22] 2243 0
Slovakia
State/province [22] 2243 0
Country [23] 2244 0
Slovenia
State/province [23] 2244 0
Country [24] 2245 0
Ukraine
State/province [24] 2245 0
Country [25] 2246 0
United States of America
State/province [25] 2246 0
Country [26] 2247 0
Canada
State/province [26] 2247 0
Country [27] 2248 0
Argentina
State/province [27] 2248 0
Country [28] 2249 0
Brazil
State/province [28] 2249 0
Country [29] 2250 0
Mexico
State/province [29] 2250 0
Country [30] 2251 0
Saudi Arabia
State/province [30] 2251 0
Country [31] 2252 0
South Africa
State/province [31] 2252 0
Country [32] 2253 0
China
State/province [32] 2253 0
Country [33] 2254 0
Korea, Democratic People's Republic Of
State/province [33] 2254 0
Country [34] 2255 0
Malaysia
State/province [34] 2255 0
Country [35] 2256 0
Singapore
State/province [35] 2256 0
Country [36] 2257 0
Thailand
State/province [36] 2257 0

Funding & Sponsors
Funding source category [1] 243839 0
Commercial sector/Industry
Name [1] 243839 0
Servier Laboratories Australia Pty Ltd
Country [1] 243839 0
Australia
Primary sponsor type
Individual
Name
Philippe Gabriel Steg
Address
Depatement de Cardiologie
Centre Hospitalier Bichat-Claude Bernard
46 rue Henri-Huchard
75018 Paris
Country
France
Secondary sponsor category [1] 237185 0
Individual
Name [1] 237185 0
Kim Fox
Address [1] 237185 0
Imperial College London,
South Kensington Campus,
London SW7 2AZ
Country [1] 237185 0
United Kingdom
Secondary sponsor category [2] 237186 0
Individual
Name [2] 237186 0
Roberto Ferrari
Address [2] 237186 0
Sant'Anna University Hospital of Ferrara, C.so Giovecca 203, 44100,
Ferrara
Country [2] 237186 0
Italy
Secondary sponsor category [3] 237187 0
Individual
Name [3] 237187 0
Ian Ford
Address [3] 237187 0
e-Science Hub
Kelvin Building
Glasgow G12 8QQ
Country [3] 237187 0
United Kingdom
Secondary sponsor category [4] 237188 0
Individual
Name [4] 237188 0
Michael Tendera
Address [4] 237188 0
Cardiology Division,
Medical University of Silesia,
Katowice
Country [4] 237188 0
Poland
Secondary sponsor category [5] 237189 0
Individual
Name [5] 237189 0
Jean Claude Tardif
Address [5] 237189 0
Montreal Heart Institute
5000, Belanger Street
Montreal, Quebec H1T 1C8
Country [5] 237189 0
Canada
Other collaborator category [1] 888 0
Individual
Name [1] 888 0
Assoc/Prof Chris Reid
Address [1] 888 0
Faculty of Medicine Nursing and Health Sciences
3rd Floor, Burnet Building, AMREP
89 Commercial Rd
Melbourne Vic 3004
Country [1] 888 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 243964 0
Bellberry Ltd
Ethics committee address [1] 243964 0
Ethics committee country [1] 243964 0
Australia
Date submitted for ethics approval [1] 243964 0
28/10/2009
Approval date [1] 243964 0
30/11/2009
Ethics approval number [1] 243964 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 30358 0
A/Prof Chris Reid
Address 30358 0
The Alfred Centre
6th Floor, 99 Commercial Road
Melbourne VIC 3004
Australia
Country 30358 0
Australia
Phone 30358 0
+ 61 3 9903 0050
Fax 30358 0
Email 30358 0
chris.reid@monash.edu
Contact person for public queries
Name 13605 0
Louise Shiel
Address 13605 0
Monash University
Caulfield Hospital
Grd Floor, Fethers Block
260 Kooyong Rd
Caulfield VIC 3162
Country 13605 0
Australia
Phone 13605 0
+61 3 9076 6169
Fax 13605 0
Email 13605 0
louise.shiel@med.monash.edu.au
Contact person for scientific queries
Name 4533 0
Louise Shiel
Address 4533 0
Monash University
Caulfield Hospital
Grd Floor, Fethers Block
260 Kooyong Rd
Caulfield VIC 3162
Country 4533 0
Australia
Phone 4533 0
+61 3 9076 6169
Fax 4533 0
Email 4533 0
louise.shiel@med.monash.edu.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.